Chiral Anthranilic Amides as Potential Cholinesterase Inhibitors: Synthesis, Bioactivity Assessment, and Molecular Modeling
 
Yazarlar (4)
Doç. Dr. Turgay TUNÇ Kırşehir Ahi Evran Üniversitesi, Türkiye
Namık Kılınç Iğdır Üniversitesi, Türkiye
Prof. Dr. Nadir DEMİREL Kırşehir Ahi Evran Üniversitesi, Türkiye
Prof. Dr. Zuhal ALIM Kırşehir Ahi Evran Üniversitesi, Türkiye
Makale Türü Açık Erişim Özgün Makale (SSCI, AHCI, SCI, SCI-Exp dergilerinde yayınlanan tam makale)
Dergi Adı Chemistry and Biodiversity (Q3)
Dergi ISSN 1612-1872 Wos Dergi Scopus Dergi
Dergi Tarandığı Indeksler SCI-Expanded
Makale Dili İngilizce Basım Tarihi 01-2025
Kabul Tarihi 12-04-2026 Yayınlanma Tarihi
Cilt / Sayı / Sayfa 22 / 11 / – DOI 10.1002/cbdv.202500974
Makale Linki https://doi.org/10.1002/cbdv.202500974
Özet
Inhibitors of acetylcholinesterase (AChE) and butyrylcholinesterase (BChE) are central therapeutic targets for Alzheimer's disease (AD). In this study, novel chiral anthranilic amide derivatives (5a–5d, 7a, and 7b) were synthesized from chiral amines and were characterized by 1H, 13C NMR, LC–MS, and IR, then inhibitory effect of 5a–5d, 7a, and 7b on AChE/BChE activity was investigated by in vitro inhibition and in silico studies. For AChE, IC50 values of 5a–5d, 7a, and 7b were found to be 70, 63.64, 53.85, 36.84, 17.07, and 17.5 nM, respectively. For BChE, IC50 values of 5a–5d, 7a, and 7b were found as 46.66 µM, 33.33 µM, 116.6 µM, 233.3 µM, 175 nM and, 116.6 nM, respectively. All compounds had better inhibition effects against AChE than BChE. The enantioselective inhibition was observed in the compounds 5a–5d. For AChE, the S‐enantiomers exhibited stronger inhibition than the R‐enantiomers …
Anahtar Kelimeler
acetylcholinesterase | butyrylcholinesterase | chiral anthranilic amide | inhibition | molecular docking
BM Sürdürülebilir Kalkınma Amaçları
Atıf Sayıları
Google Scholar 1
Web of Science 1
Chiral Anthranilic Amides as Potential Cholinesterase Inhibitors: Synthesis, Bioactivity Assessment, and Molecular Modeling

Paylaş